News

In case you missed them, we've compiled the top five infectious disease articles from this past week.

We’ve compiled the best ways to fight back against colds and flu viruses this holiday season.

Scientists are working on developing preventive and therapeutic strategies that target both HIV and herpes, as having herpes may make individuals more vulnerable to contracting HIV.

The Interagency Food Safety Analytics Collaboration released a report that sheds light on the types of food that contribute to food-borne illness.

For young adults without risk factors for HIV, a new study finds several benefits to a one-time routine screening at age 25.

For all you last-minute shoppers, Payal K. Patel MD, MPH, and Sujit Suchindran MD, have put together a wish list of the top items to get the infectious disease physician in your life.

A new study conducted by University of Texas Health Science Center at Houston investigators finds that male virgins can still acquire HPV, underscoring the need for vaccination.

Investigators from the Duke Human Vaccine Institute have developed a binding assay capable of more accurately identifying new versus long-standing HIV infections.

Anal high-risk human papillomavirus (HPV) infections are known to lead to anal cancer.

The first step in global health security is prevention, but how does it work against a diverse range of threats?

More states are reporting widespread flu activity as CDC researchers up their annual estimate of flu deaths around the world.

Two recent federal government decisions and actions could put the public at increased risk for an infectious disease outbreak.

The FDA issues a final rule on the safety and effectiveness of certain active ingredients in over-the-counter health care antiseptic products.

One intensive care unit utilized advanced infection control efforts to tackle an outbreak and won.

Individuals with an egg allergy do not need to avoid the annual flu shot.

Vitamin D is known to boost bone health, but a recent study demonstrates that it has little impact on the metabolic side effects of a newly begun antiretroviral therapy (ART) regime.

The expansion in tick populations has led to an increased risk of infection for humans and animals with both established tick-borne agents and newly recognized ones, creating a serious One Health problem.

The Infectious Diseases Society of America’s (IDSA) decision not to endorse the 2016 Surviving Sepsis Campaign Guidelines comes from disagreement on the diagnosis and management of the microbial etiology of the disease.

The US Food and Drug Administration (FDA) has approved Ortho Clinical Diagnostics' VITROS Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator on the VITROS 3600 Immunodiagnostic System.

A surprising source of this opportunistic pathogen was found through environmental testing.

Forty years after the first Ebola outbreak in the Democratic Republic of Congo, investigators find that a small group of survivors are still producing virus-fighting antibodies.

In case you missed them, we've compiled the top 5 articles from this past week.

In case you were wondering what to get the infectious disease (ID) pharmacist in your life for the upcoming holidays.

The results of a new study show that when a best practice advisory (BPA) displayed in the electronic health record of patients in the baby boomer generation, it prompted a 5-fold increase in screening for hepatitis C virus (HCV) in this population.

Hepatitis C is more curable than ever thanks to direct-acting antivirals, and now, a new study shows how expanded access to these drugs through Medicaid is helping more individuals get treated.

Authors of a new Policy Forum suggest an alternative approach to regulating fecal microbiota transplantation.

New CDC study yields higher estimate of seasonal flu-related deaths worldwide.

A new study from investigators at Drexel University revealed that if 25% of high-risk men who have sex with men appropriately used the pre-exposure prophylaxis (PrEP), 3 out of every 10 HIV infections in this population could be prevented.

By making this information available the FDA hopes to help improve patient outcomes, better manage antibiotic use, and decrease antimicrobial resistance.

Investigators from George Mason University have developed another diagnostic method for tuberculosis (TB), a highly sensitive and specific urine test.